TY - JOUR
T1 - Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association (HFA) of the ESC
AU - Metra, Marco
AU - Tomasoni, Daniela
AU - Adamo, Marianna
AU - Bayes‐Genis, Antoni
AU - Filippatos, Gerasimos
AU - Abdelhamid, Magdy
AU - Adamopoulos, Stamatis
AU - Anker, Stefan D.
AU - Antohi, Laura
AU - Böhm, Michael
AU - Braunschweig, Frieder
AU - Gal, Tuvia Ben
AU - Butler, Javed
AU - Cleland, John G.F.
AU - Cohen‐Solal, Alain
AU - Damman, Kevin
AU - Gustafsson, Finn
AU - Hill, Loreena
AU - Jankowska, Ewa
AU - Lainscak, Mitja
AU - Lund, Lars H.
AU - McDonagh, Theresa
AU - Mebazaa, Alexandre
AU - Moura, Brenda
AU - Mullens, Wilfried
AU - Piepoli, Massimo
AU - Ponikowski, Piotr
AU - Rakisheva, Amina
AU - Ristic, Arsen
AU - Savarese, Gianluigi
AU - Seferovic, Petar
AU - Sharma, Rajan
AU - Tocchetti, Carlo Gabriele
AU - Yılmaz, Mehmet Birhan
AU - Vitale, Cristiana
AU - Volterrani, Maurizio
AU - Von Haehling, Stephan
AU - Chioncel, Ovidiu
AU - Coats, Andrew JS
AU - Rosano, Giuseppe
PY - 2023/6/1
Y1 - 2023/6/1
N2 - Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic heart failure (HF). These events are associated with poorer quality of life, increased risks of hospitalization and death and are a major burden on healthcare resources. They usually require diuretic therapy, either administered intravenously or by escalation of oral doses or with combinations of different diuretic classes. Additional treatments may also have a major role, including initiation of guideline-recommended medical therapy (GRMT). Hospital admission is often necessary but treatment in the emergency service or in outpatient clinics or by primary care physicians has become increasingly used. Prevention of first and recurring episodes of worsening HF is an essential component of HF treatment and this may be achieved through early and rapid administration of GRMT. The aim of the present clinical consensus statement by the Heart Failure Association of the European Society of Cardiology is to provide an update on the definition, clinical characteristics, management and prevention of worsening HF in clinical practice.
AB - Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic heart failure (HF). These events are associated with poorer quality of life, increased risks of hospitalization and death and are a major burden on healthcare resources. They usually require diuretic therapy, either administered intravenously or by escalation of oral doses or with combinations of different diuretic classes. Additional treatments may also have a major role, including initiation of guideline-recommended medical therapy (GRMT). Hospital admission is often necessary but treatment in the emergency service or in outpatient clinics or by primary care physicians has become increasingly used. Prevention of first and recurring episodes of worsening HF is an essential component of HF treatment and this may be achieved through early and rapid administration of GRMT. The aim of the present clinical consensus statement by the Heart Failure Association of the European Society of Cardiology is to provide an update on the definition, clinical characteristics, management and prevention of worsening HF in clinical practice.
KW - Worsening heart failure
KW - Hospitalization
KW - Emergency department visits
KW - Outpatients
KW - Intensification of oral therapy
KW - Prognosis
UR - https://pure.qub.ac.uk/en/publications/worsening-of-chronic-heart-failure-definition-epidemiology-manage
U2 - 10.1002/ejhf.2874
DO - 10.1002/ejhf.2874
M3 - Article
SN - 1879-0844
VL - 25
SP - 776
EP - 791
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
IS - 6
ER -